The Clostridioides Difficile Trial of REC-3964
Trial details
- Registry ID
- NCT06536465
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| The Clostridioides Difficile Trial of REC-3964NCT06536465 | RXRX | Phase 2 | Terminated | 2025-05-06Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |